Pharmafile Logo
Pharmafocus logo
Advanced Search

patent expiry

Showing 6 posts of 6 posts found.

v2_crestor_10_mg

Allergan launches Crestor generic in the US

May 3, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, AstraZeneca, Crestor, FDA, FDA Approval, cholesterol, generic, patent, patent expiry, sales

Allergan has received FDA approval on the generic version of AstraZeneca’s high cholesterol drug, Crestor (rosuvastatin), and has become the …

News
Ian Read

Lipitor losses hit Pfizer

May 2, 2012
Sales and Marketing Alzheimer's, Lipitor, Pfizer, patent expiry

Lipitor’s US patent expiry has inflicted heavy damage on Pfizer’s revenues, with global sales down 7% in the first three …

News
pfizer_hq_street_web

Prevnar and Lyrica lift Pfizer results

November 1, 2011
Research and Development, Sales and Marketing Lipitor, Lyrica, Pfizer, Prevnar, patent expiry

Strong sales of Lyrica and its Prevnar vaccines coupled with favourable exchange rates have helped Pfizer deliver a strong quarter.  …

News

Health service’s £1bn patent expiry windfall

October 14, 2011
Sales and Marketing generics, patent expiry

Patent expiries could shave £1 billion from  the NHS drugs bill, and could yield major savings by 2015 for the …

Feature

Lilly posts strong quarterly results, faces challenges ahead

July 22, 2011
Sales and Marketing lilly, patent expiry

Lilly edged toward double-digit growth in the second quarter, but looming patent expires threaten this trend. Second quarter revenue grew …

News

AstraZeneca revenues reach standstill

January 31, 2011
Sales and Marketing AstraZeneca, Full year 2010, patent expiry, results

AstraZeneca’s revenues came to a virtual standstill in 2010, with strong growth outside the US being offset by generic competition …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026